Detalhe da pesquisa
1.
[Evidence map of clinical research on Chinese patent medicines for post-acute myocardial infarction heart failure].
Zhongguo Zhong Yao Za Zhi
; 49(6): 1673-1682, 2024 Mar.
Artigo
em Zh
| MEDLINE | ID: mdl-38621951
2.
[Network Meta-analysis of Chinese patent medicine in treatment of heart failure with preserved ejection fraction].
Zhongguo Zhong Yao Za Zhi
; 49(3): 819-835, 2024 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-38621886
3.
[Effect of astragaloside â £ on angiotensin â ¡-induced inflammatory response of vascular endothelial cells and mechanism].
Zhongguo Zhong Yao Za Zhi
; 47(21): 5900-5907, 2022 Nov.
Artigo
em Zh
| MEDLINE | ID: mdl-36472009
4.
[Systematic evaluation and trail sequential analysis of efficacy and safety of Yangxue Qingnao Granules in treatment of essential hypertension and its accompanying symptoms].
Zhongguo Zhong Yao Za Zhi
; 46(6): 1523-1536, 2021 Mar.
Artigo
em Zh
| MEDLINE | ID: mdl-33787151
5.
[Systematic evaluation of efficacy and safety of Songling Xuemaikang Capsules in treatment of essential hypertension].
Zhongguo Zhong Yao Za Zhi
; 46(2): 467-477, 2021 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-33645136
6.
The Guizhi Gancao Decoction Attenuates Myocardial Ischemia-Reperfusion Injury by Suppressing Inflammation and Cardiomyocyte Apoptosis.
Evid Based Complement Alternat Med
; 2019: 1947465, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30800167